Mirae Asset Global ETFs Holdings’s PTC Therapeutics PTCT Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio PTCT Stock Details PTCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.47M	Sell	42,550 -8,518	-17%	-$615K	﹤0.01%	1002
2026 Q1	$3.47M	Buy	51,068 +925	+2%	+$65.5K	﹤0.01%	952
2025 Q4	$3.81M	Sell	50,143 -4,449	-8%	-$323K	0.01%	891
2025 Q3	$3.35M	Sell	54,592 -5,658	-9%	-$295K	0.01%	939
2025 Q2	$2.95M	Buy	60,250 +169	+0.3%	+$8.02K	0.01%	924
2025 Q1	$3.07M	Sell	60,081 -5,600	-9%	-$279K	0.01%	921
2024 Q4	$2.97M	Buy	65,681 +205	+0.3%	+$8.77K	0.01%	937
2024 Q3	$2.43M	Buy	65,476 +5,778	+10%	+$193K	0.01%	1031
2024 Q2	$1.84M	Buy	+59,698	New	+$1.93M	﹤0.01%	1118

Other funds holding PTCT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's PTCT Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings reduced its PTC Therapeutics (PTCT) stake by 17% in Q2 2026, selling an estimated $615K and leaving 42,550 shares worth $3.47M. The position accounts for ﹤0.01% of the portfolio, ranked #1002.

Mirae Asset Global ETFs Holdings first reported a position in PTCT in Q2 2024 and has held it in 9 quarters since. The position peaked at $3.81M in Q4 2025. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

Mirae Asset Global ETFs Holdings held 42,550 shares of PTC Therapeutics worth $3.47M as of Q2 2026.
Mirae Asset Global ETFs Holdings sold 8,518 PTC Therapeutics shares in Q2 2026, an estimated $615K.
PTC Therapeutics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1002 holding.
Mirae Asset Global ETFs Holdings first reported a position in PTC Therapeutics in Q2 2024 and has held it in 9 quarters since.
Mirae Asset Global ETFs Holdings's PTC Therapeutics position peaked at $3.81M in Q4 2025.
382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.